SCHEMBL756208

SCHEMBL756208

NOC(=O)[C@@H](N)CSSC[C@H](N)C(=O)ON

nearest known ligand 0.39

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1816662 0.91 ARG1 (0.40) KIF11
SCHEMBL28845173 0.86 TSHR (0.37) KIF11
SCHEMBL14645189 0.81 ALOX15 (0.32)
SCHEMBL2400319 0.79 ALDH1A1 (0.38)
SCHEMBL174379 0.79
SCHEMBL4260594 0.79
SCHEMBL2157572 0.78 PTGS1 (0.32)
SCHEMBL12438525 0.78 KIF11 (0.43) KIF11
SCHEMBL515397 0.78
SCHEMBL111172 0.78 KIF11 (0.43) KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196276-A1 PREPARATION OF GAMMA L-GLUTAMYL L-CYSTEINE AND BIS GAMMA L-GLUTAMYL CYCSTINE CHILDREN'S NATIONAL MEDICAL CENTER (US) 2023-10-12 WO claimed
US-20200069551-A1 COMPOSITION FOR IMPROVING HAIR HEALTH K18, INC. 2020-03-05 US claimed
CN-106432496-A Anti-CD79B antibodies and immunoconjugates and methods of use 健泰科生物技术公司 2017-02-22 CN claimed
WO-2024151608-A2 SYSTEMS, METHODS, AND COMPOSITIONS INVOLVING PRETREATMENT AND/OR ENZYMATIC DEGRADATION OF CRYSTALLIZABLE POLYMERS, INCLUDING COPOLYMERS Protein Evolution Inc. (US) 2024-07-18 WO disclosed
US-20240228728-A1 SYSTEMS AND METHODS FOR ENZYMATIC DEGRADATION OF POLYMERS, INCLUDING COPOLYMERS, OF ADVANTAGOUS PARTICLE SIZE Protein Evolution Inc. (US) 2024-07-11 US disclosed
US-20240228727-A1 SYSTEMS AND METHODS FOR PRETREATMENT AND/OR ENZYMATIC DEGRADATION OF CRYSTALLIZABLE POLYMERS, INCLUDING COPOLYMERS Protein Evolution Inc. (US) 2024-07-11 US disclosed
CN-118284706-A Compositions and methods for densely packed analyte analysis 加利福尼亚太平洋生物科学股份有限公司 2024-07-02 CN disclosed
CN-117482248-A Novel nucleic acid base bionic nanogel carrier and preparation method and application thereof 吉林化工学院 2024-02-02 CN disclosed
WO-2023196276-A1 PREPARATION OF GAMMA L-GLUTAMYL L-CYSTEINE AND BIS GAMMA L-GLUTAMYL CYCSTINE CHILDREN'S NATIONAL MEDICAL CENTER (US) 2023-10-12 WO disclosed
US-20230257427-A1 INSECTICIDAL PEPTIDE PRODUCTION, PEPTIDE EXPRESSION IN PLANTS AND COMBINATIONS OF CYSTEINE RICH PEPTIDES Vestaron Corporation (US) 2023-08-17 US disclosed
US-11692016-B2 High gene expression yeast strain SUTERRA LLC 2023-07-04 US disclosed
EP-0420934-B1 BIFUNCTIONAL COUPLING AGENTS AND RADIONUCLIDE LABELED COMPOSITIONS PREPARED THEREFROM CENTOCOR INC (US) 1994-09-21 EP disclosed
WO-1994015958-A2 PEPTIDE INHIBITORS OF CELL ADHESION TANABE SEIYAKU CO., LTD. (JP) 1994-07-21 WO disclosed
US-5218128-A Medical disgnosis CENTOCOR, INC. (US) 1993-06-08 US disclosed
US-5144043-A Coupling protein or peptide to radionucleotide; labeling antibodies CENTOCOR (US) 1992-09-01 US disclosed
US-5053503-A For joining antibodies and metallic radionuclides CENTOCOR (US) 1991-10-01 US disclosed
EP-0420934-A1 BIFUNCTIONAL COUPLING AGENTS AND RADIONUCLIDE LABELED COMPOSITIONS PREPARED THEREFROM. CENTOCOR INC (US) 1991-04-10 EP disclosed
WO-1989012625-A1 BIFUNCTIONAL COUPLING AGENTS AND RADIONUCLIDE LABELED COMPOSITIONS PREPARED THEREFROM CENTOCOR, INC. (US) 1989-12-28 WO disclosed
US-4345032-A THIOAMINOACIDS, FECES SEIKENKAI (JP) 1982-08-17 US disclosed
US-4287219-A Fibrous edible proteins having fat particles homogeneously dispersed therethrough RHONE-POULENC INDUSTRIES (FR) 1981-09-01 US disclosed